Pages that link to "Q42384038"
Jump to navigation
Jump to search
The following pages link to Rosiglitazone disrupts endosteal bone formation during distraction osteogenesis by local adipocytic infiltration (Q42384038):
Displaying 8 items.
- Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass (Q27334866) (← links)
- Current Protocols in Mouse Biology (Q34972041) (← links)
- Tributyltin engages multiple nuclear receptor pathways and suppresses osteogenesis in bone marrow multipotent stromal cells (Q36533766) (← links)
- Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review (Q38441017) (← links)
- Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future (Q38641190) (← links)
- Bone-Conditioned Medium Inhibits Osteogenic and Adipogenic Differentiation of Mesenchymal Cells In Vitro (Q42807602) (← links)
- The Impact of Type 2 Diabetes on Bone Fracture Healing (Q49294423) (← links)
- The Unique Metabolic Characteristics of Bone Marrow Adipose Tissue (Q64244082) (← links)